Association of nitric oxide synthase 3 gene polymorphism with the risk of type 2 diabetes

Garme,Yasaman; Saravani,Ramin; Galavi,Hamid Reza

doi:10.3892/br.2017.916

Association of nitric oxide synthase 3 gene polymorphism with the risk of type 2 diabetes

Authors:
- Yasaman Garme
- Ramin Saravani
- Hamid Reza Galavi
View Affiliations

Affiliations: Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 98167‑43463, Iran
Published online on: May 22, 2017 https://doi.org/10.3892/br.2017.916
Pages: 85-89

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Type‑2 diabetes (T2D) is a multifactorial (environmental and genetic factors) and global epidemic disease with an estimated high prevalence worldwide. Studies have indicated that nitric oxide synthase 3 (NOS3) has several important roles in the pathogenesis of T2D. The present study aims to investigate the association between NOS3 rs1800779(A/G) and T2D in an Iranian sample population. A case‑control study was conducted on 250 T2D patients and 250 healthy control subjects (HCs). Genotyping of the rs1800779(A/G) variant was conducted using a Tetra‑Amplification Refractory Mutation System polymerase chain reaction. The frequencies of genotypes AA, AG and GG polymorphisms were 56.8, 39.2 and 4% in the T2D group, and 42.8, 56 and 1.2% in the HCs group, respectively. The frequency of the minor (G) allele was 23.6% in the T2D group and 29.2% in the HCs group. The genotype frequencies of the rs1800779(A/G) variant demonstrated statistically significant differences between T2D and controls in a codominant model (AG vs. AA, OR=0.527, 95% CI=0.368‑0.756, P<0.001) and dominant model (AG+GG vs. AA, OR=0.569, 95% CI=0.399‑0.811, P=0.002). There was no significant association between clinical and demographic characteristics and the NOS3 rs1800779(A/G) polymorphism in dominant status (P>0.05). The dominant model and AG genotype of NOS3 rs1800779(A/G) polymorphism may had a protective effect on T2D of Iranian population.

View Figures

View References

1	Esser N, Legrand-Poels S, Piette J, Scheen AJ and Paquot N: Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 105:141–150. 2014. View Article : Google Scholar : PubMed/NCBI
2	Shoelson SE, Herrero L and Naaz A: Obesity, inflammation, and insulin resistance. Gastroenterology. 132:2169–2180. 2007. View Article : Google Scholar : PubMed/NCBI
3	Sing CF, Stengård JH and Kardia SL: Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 23:1190–1196. 2003. View Article : Google Scholar : PubMed/NCBI
4	Loscalzo J and Welch G: Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 38:87–104. 1995. View Article : Google Scholar : PubMed/NCBI
5	Kraus WE: Genetic approaches for the investigation of genes associated with coronary heart disease. Am Heart J. 140:S27–S35. 2000. View Article : Google Scholar : PubMed/NCBI
6	Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM and Brown MJ: A common variant of the endothelial nitric oxide synthase (Glu298-> Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 100:1515–1520. 1999. View Article : Google Scholar : PubMed/NCBI
7	Galavi HR, Saravani R, Alamdari AR, Ranjbar N, Damani E and Khodakhier TN: Evaluating the effect of the rs2229238 and the rs4845625 interleukin 6 receptor gene polymorphisms on body mass index and the risk of type 2 diabetes in an iranian study population. Int J High Risk Behav Addiction. 5:e332892016.
8	Saravani R, Irani Z and Galavi HR: Evaluation of transcription factor 7 like 2 polymorphisms and haplotypes in risk of type 2 diabetes. Revista Romana de Medicina de Laborator. 24:423–430. 2016. View Article : Google Scholar
9	Saravani S, Miri H, Saravani R, Yari D, Nakhaee A and Mahjoubifard M: Association of catalase (rs7943316) and glutathione peroxidase-1 (rs1050450) polymorphisms with the risk of type 2 diabetes (T2DM). Mol Genet Microbiol Virol. 30:216–220. 2015. View Article : Google Scholar
10	Lowenstein CJ, Dinerman JL and Snyder SH: Nitric oxide: A physiologic messenger. Ann Intern Med. 120:227–237. 1994. View Article : Google Scholar : PubMed/NCBI
11	Karvonen J, Kauma H, Kervinen K, Rantala M, Ikäheimo M, Päivänsalo M, Savolainen MJ and Kesäniemi YA: Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med. 251:102–110. 2002. View Article : Google Scholar : PubMed/NCBI
12	Bressler J, Pankow JS, Coresh J and Boerwinkle E: Interaction between the NOS3 gene and obesity as a determinant of risk of type 2 diabetes: The atherosclerosis risk in communities study. PLoS One. 8:e794662013. View Article : Google Scholar : PubMed/NCBI
13	Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI and Kern LM: Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 151:775–783. 2009. View Article : Google Scholar : PubMed/NCBI
14	Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G and Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 97:2601–2610. 1996. View Article : Google Scholar : PubMed/NCBI
15	Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC and Schappert KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 268:17478–17488. 1993.PubMed/NCBI
16	Ferguson JF, Phillips CM, McMonagle J, Pérez-Martínez P, Shaw DI, Lovegrove JA, Helal O, Defoort C, Gjelstad IM, Drevon CA, et al: NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease and interact with omega-3 polyunsaturated fatty acids. Atherosclerosis. 211:539–544. 2010. View Article : Google Scholar : PubMed/NCBI
17	Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB, Hotamisligil GS, Ridker PM, Rodriguez BL, Margolis KL, et al: Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes. 56:1898–1904. 2007. View Article : Google Scholar : PubMed/NCBI
18	Meigs JB, Hu FB, Rifai N and Manson JE: Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 291:1978–1986. 2004. View Article : Google Scholar : PubMed/NCBI
19	Möllsten A, Lajer M, Jorsal A and Tarnow L: The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Molecular genetics and metabolism. 97:80–84. 2009. View Article : Google Scholar : PubMed/NCBI
20	Li J, Tao F, Wu X, Tan Y, He L and Lu H: Polymorphic variations in manganese superoxide dismutase (MnSOD) and endothelial nitric oxide synthase (eNOS) genes contribute to the development of type 2 diabetes mellitus in the Chinese Han population. Genet Mol Res. 14:12993–13002. 2015. View Article : Google Scholar : PubMed/NCBI
21	American Diabetes Association, . Standards of medical care in diabetes. Diabetes Care. 27 Suppl 1:S15–S35. 2004. View Article : Google Scholar : PubMed/NCBI
22	Saravani R, Galavi HR, Ranjbar N and Alamdari AR: ATP-binding cassette transporter A1 polymorphisms and haplotypes in risk of type 2 diabetes. Gene Cell Tissue. 4:e436772016. View Article : Google Scholar
23	Saravani S, Yari D, Saravani R and Ahmadabadi CA: Association of COL4A3 (rs55703767), MMP-9 (rs17576) and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes. Biomed Rep. 6:329–334. 2017.PubMed/NCBI
24	Mousavi M, Saravani R, Modrek MJ, Shahrakipour M and Sekandarpour S: Detection of toxoplasma gondii in diabetic patients using the nested PCR assay via RE and B1 genes. Jundishapur J Microbiol. 9:e294932016. View Article : Google Scholar : PubMed/NCBI
25	Haffner SM, Lehto S, Rönnemaa T, Pyörälä K and Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:229–234. 1998. View Article : Google Scholar : PubMed/NCBI
26	Stern MP and Haffner SM: Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis. 6:123–130. 1986. View Article : Google Scholar : PubMed/NCBI
27	Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, et al: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 88:E14–E22. 2001. View Article : Google Scholar : PubMed/NCBI
28	Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK and Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:2510–2516. 1993. View Article : Google Scholar : PubMed/NCBI
29	De Vriese AS, Verbeuren TJ, van de Voorde J, Lameire NH and Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol. 130:963–974. 2000. View Article : Google Scholar : PubMed/NCBI
30	McVeigh G, Brennan G, Johnston G, McDermott BJ, McGrath LT, Henry WR, Andrews JW and Hayes JR: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35:771–776. 1992.PubMed/NCBI
31	Kahn BB and Flier JS: Obesity and insulin resistance. J Clin Invest. 106:473–481. 2000. View Article : Google Scholar : PubMed/NCBI
32	Haffner SM: Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract. 61 Suppl 1:S9–S18. 2003. View Article : Google Scholar : PubMed/NCBI
33	Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES and Veves A: Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 48:1856–1862. 1999. View Article : Google Scholar : PubMed/NCBI
34	Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA and Van Bortel LM: The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J Hypertens. 17:1831–1835. 1999. View Article : Google Scholar : PubMed/NCBI
35	Rittig K, Hieronimus A, Thamer C, Machann J, Peter A, Stock J, Schick F, Fritsche A, Stefan N, Häring HU and Balletshofer B: Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals. Atherosclerosis. 212:575–579. 2010. View Article : Google Scholar : PubMed/NCBI
36	Thameem F, Puppala S, Arar NH, Stern MP, Blangero J, Duggirala R and Abboud HE: Endothelial nitric oxide synthase (eNOS) gene polymorphisms and their association with type 2 diabetes-related traits in Mexican Americans. Diab Vasc Dis Res. 5:109–113. 2008. View Article : Google Scholar : PubMed/NCBI
37	Chen F, Li YM, Yang LQ, Zhong CG and Zhuang ZX: Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population. IUBMB life. 68:516–525. 2016. View Article : Google Scholar : PubMed/NCBI
38	Conen D, Glynn RJ, Buring JE, Ridker PM and Zee RY: Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: A prospective cohort study. J Intern Med. 263:376–385. 2008. View Article : Google Scholar : PubMed/NCBI
39	Zintzaras E, Papathanasiou AA and Stefanidis I: Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis. Genet Med. 11:695–706. 2009. View Article : Google Scholar : PubMed/NCBI
40	Makuc J and Petrovic D: No association between NOS2 and NOS3 polymorphisms and diabetic nephropathy in type 2 diabetics. Central European Journal of Biology. 7:404–410. 2012.
41	Chen Y, Huang H, Zhou J, et al: Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol Vis. 13:2142–2147. 2007.PubMed/NCBI
42	Zheleznyakova A, Vikulova O, Nosikov V and Shestakova M: The impact of polymorphisms in NOS3, APOB, KCNJ11, TCF7L2 genes on development of chronic kidney disease in type 2 diabetic patients. Exper Clin Endoc Diabetes. 122:LB162014.
43	Zakerjafari M, Mayali AM and Tavangar P: Evaluation of NOS3 gene rs1800779 polymorphism in Iranian patients affected by coronary-heart disease patients and normal individuals. Adv Biores. 7:16–21. 2016.